Trajectories of prices in generic drug markets: what can we infer from looking at trajectories rather than average prices?

被引:0
作者
Antonio J. Trujillo
Jose C. Gutierrez
Emmanuel E. Garcia Morales
Mariana Socal
Jeromie Ballreich
Gerard Anderson
机构
[1] Bloomberg School of Public Health,Department of International Health
[2] Johns Hopkins University,Department of Epidemiology, Bloomberg School of Public Health
[3] Johns Hopkins University,undefined
[4] Department of Health Policy and Management,undefined
[5] Bloomberg School of Public Health,undefined
[6] Johns Hopkins University,undefined
来源
Health Economics Review | / 12卷
关键词
Generic drugs; Group based trajectory models; Mergers and acquisitions; Drug; Prices;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 80 条
[1]  
Allen NB(2014)Blood pressure trajectories in early adulthood and subclinical atherosclerosis in middle age Jama 311 490-497
[2]  
Siddique J(2018)Data resources for conducting health services and policy research Annu Rev Public Health 39 437-452
[3]  
Wilkins JT(2017)Possible insufficiency of generic price competition to contain prices for orally administered anticancer therapies JAMA Intern Med 177 1679-1680
[4]  
Shay C(2017)High generic drug prices and market competition: a retrospective cohort study Ann Intern Med 167 145-151
[5]  
Lewis CE(2006)Association of income and prescription drug coverage with generic medication use among older adults with hypertension Am J Manag Care 12 611-796
[6]  
Goff DC(2013)Group-based trajectory models: a new approach to classifying and predicting long-term medication adherence Med Care 51 789-83
[7]  
Jacobs DR(2019)The contribution of new product entry versus existing product inflation in the rising costs of drugs Health Aff 38 76-87
[8]  
Liu K(2019)Cognitive ageing trajectories and mortality of chinese oldest-old Arch Gerontol Geriatr 82 81-613
[9]  
Lloyd-Jones D(2013)A note on a stata plugin for estimating group-based trajectory models Sociol Methods Res 42 608-1586
[10]  
Blewett LA(2018)Generic drug price hikes and out-of-pocket spending for medicare beneficiaries Health Aff 37 1578-e127